EFFECT OF NMDA ANTAGONISTS ON RAPID AND CHRONIC TOLERANCE TO ETHANOL - IMPORTANCE OF INTOXICATED PRACTICE

被引:36
作者
KHANNA, JM
MORATO, GS
CHAU, A
SHAH, G
KALANT, H
机构
[1] UNIV TORONTO,DEPT PHARMACOL,TORONTO M5S 1A8,ON,CANADA
[2] ADDICT RES FDN,TORONTO M5S 2S1,ON,CANADA
[3] UNIV FED SANTA CATARINA,DEPT PHARMACOL,BR-88049 FLORIANOPOLIS,SC,BRAZIL
关键词
TOLERANCE; NMDA ANTAGONISTS; (+)MK-801; KETAMINE; CHRONIC; RAPID;
D O I
10.1016/0091-3057(94)90343-3
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Recent studies from our laboratory have shown that NMDA antagonists ((+)MK-801 and ketamine) inhibit the development of both rapid and chronic tolerance to the motor-impairing (moving belt test) and hypothermic effects of ethanol. The present experiments were designed to determine a) the generality of this inhibition, by using a different test of motor function, the tilt-plane test, and b) the possible importance of the experimental paradigm (i.e., with and without intoxicated practice), for the effect of the NMDA antagonist on ethanol tolerance. Daily administration of ethanol 3.3 g/kg for 5 days produced the same degree of tolerance on this test, whether it was given as a single dose of 3.3 g/kg before the daily training session or as divided doses of 2.3 g/kg before and 1 g/kg immediately after the session. The inhibitory effect of a single dose of (+)MK-801 (0.25 mg/kg IF) on rapid tolerance did not last longer than 1 day. Therefore, daily administration of the NMDA antagonists was necessary to block development of chronic tolerance. Daily injection of(+)MK-801 (0.25 mg/kg IP) failed to block chronic tolerance, but inclusion of a second dose of (+)MK-80l daily, and progressive increase of this second dose during the chronic treatment period did block chronic tolerance. Unlike (+)MK-801, ketamine does not have motor-impairing effects of its own, and does not potentiate those of ethanol; it was, therefore, used in the remaining experiments. Groups of rats received ethanol (3.3 g/kg) or saline, either before a daily practice session on the tilt-plane or after it. Tolerance to the ethanol effect developed on both regimens, but more rapidly in the animals receiving ethanol before the practice sessions. Ketamine inhibited the development of tolerance in the before group, but had no effect on the tolerance development in the after group. These results suggest that ketamine will block only practice-learned tolerance and not tolerance acquired purely by pharmacological exposure, and posttrial administration of ketamine was ineffective in blocking tolerance. These experiments provide further evidence consistent with the hypothesis that NMDA antagonists block tolerance development through inhibition of learning.
引用
收藏
页码:755 / 763
页数:9
相关论文
共 36 条
[1]  
ARVOLA A, 1958, Q J STUD ALCOHOL, V19, P563
[2]   CHRONIC ADMINISTRATION OF MK-801 AND THE NMDA RECEPTOR - FURTHER EVIDENCE FOR REDUCED SENSITIVITY OF THE PRIMARY ACCEPTOR SITE FROM STUDIES WITH THE CORTICAL WEDGE PREPARATION [J].
BEART, PM ;
LODGE, D .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1990, 42 (05) :354-355
[3]   THE NMDA RECEPTOR ANTAGONIST-MK-801 PREVENTS LONG-LASTING NONASSOCIATIVE MORPHINE-TOLERANCE IN THE RAT [J].
BENELIYAHU, S ;
MAREK, P ;
VACCARINO, AL ;
MOGIL, JS ;
STERNBERG, WF ;
LIEBESKIND, JC .
BRAIN RESEARCH, 1992, 575 (02) :304-308
[4]   A STUDY OF ALCOHOL-TOLERANCE EFFECT AND AN INTRODUCTION OF A NEW BEHAVIOURAL TECHNIQUE [J].
CHEN, CS .
PSYCHOPHARMACOLOGIA, 1968, 12 (05) :433-&
[5]   FURTHER NOTE ON STUDIES OF ACQUIRED BEHAVIORAL TOLERANCE TO ALCOHOL [J].
CHEN, CS .
PSYCHOPHARMACOLOGIA, 1972, 27 (03) :265-&
[6]   EFFECT OF CGS-19755, A COMPETITIVE N-METHYL-D-ASPARTATE ANTAGONIST, ON GENERAL ANESTHETIC POTENCY [J].
DANIELL, LC .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 40 (04) :767-769
[7]  
DANIELL LC, 1992, J PHARMACOL EXP THER, V261, P304
[8]   LEARNING IMPAIRMENT IN RATS BY N-METHYL-D-ASPARTATE RECEPTOR ANTAGONISTS [J].
DANYSZ, W ;
WROBLEWSKI, JT ;
COSTA, E .
NEUROPHARMACOLOGY, 1988, 27 (06) :653-656
[9]  
Foster AC, 1991, EXCITATORY AMINO ACI, P164
[10]  
GOLDSTEIN DB, 1974, J PHARMACOL EXP THER, V190, P377